WHO ICTRP trial
A randomized controlled clinical study on the improvement of cognitive…
ChiCTR2000037370 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000037370 |
|---|---|
| Public title | A randomized controlled clinical study on the improvement of cognitive impairment in patients with schizophrenia by replacing BDZ with agomelatin |
| Scientific title | A randomized controlled clinical study on the improvement of cognitive impairment in patients with schizophrenia by replacing BDZ with agomelatin |
| Primary sponsor | Shanghai Mental Health Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Schizophrenia |
| Interventions | experimental group:Agomelatine;control groupp:No intervention |
| Registration date | Aug 28, 2020 |
| Target size | experimental group:50;control groupp:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: